Qiu-yuan Xiang1
Ji-Hao Zhou- 1Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China
- 2Department of Pathology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China
- 3Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China
By Xiang Q-y, Zuo M, Zhou J-H and Feng C (2025) Front. Immunol. 6:1583405. doi: 10.3389/fimmu.2025.1583405
Wrong affiliation, but not replacing with present address
Author “Min Zuo” was erroneously assigned to affiliation “Department of Pathology, The Second Clinical Medical College of Jinan University, Shenzhen, China”.
The correct affiliation is “Department of Pathology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China”.
Authors “Ji-Hao Zhou and Chun Feng” were erroneously assigned to affiliation “Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China”.
The correct affiliation is “Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: activated phosphoinositide 3-kinase δ syndrome, Epstein-Barr virus, diffuse large B-cell lymphoma, Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+ DLBCL), inborn error of immunity
Citation: Xiang Q-y, Zuo M, Zhou J-H and Feng C (2025) Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review. Front. Immunol. 16:1659197. doi: 10.3389/fimmu.2025.1659197
Received: 03 July 2025; Accepted: 04 July 2025;
Published: 15 July 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Xiang, Zuo, Zhou and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ji-Hao Zhou, emhvdWppaGFvQGFsaXl1bi5jb20=; Chun Feng, ZmVuZ2NoOEBxcS5jb20=